Tetra Discovery Partners

Tetra Discovery Partners is a pharmaceutical drug development company development medicines for Alzheimer's Disease, Traumatic Brain Injury, and schizophrenia.  The drugs in our pipeline offer a new mechanism focused on PDE4B and PDE4D.

Tetra designs drugs to treat memory loss and cognitive impairment by improving how the brain processes and stores information.

Tetra's promising drug for Alzheimer's Disease, BPN-14770, is being developed in partnership with the NIH Blueprint Therapeutics program.

Company Growth (employees)
Grand Rapids, US
Size (employees)
9 (est)
Tetra Discovery Partners was founded in 2010 and is headquartered in Grand Rapids, US

Tetra Discovery Partners Office Locations

Tetra Discovery Partners has an office in Grand Rapids
Grand Rapids, US (HQ)
Cook-DeVos Center for Health Sciences 301 Michigan St NE

Tetra Discovery Partners Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$12.4 m

Latest funding size

$5 m

Time since last funding

about 1 year


Tetra Discovery Partners's latest funding round in November 2016 was reported to be $5 m. In total, Tetra Discovery Partners has raised $12.4 m

Tetra Discovery Partners's Web-traffic and Trends

Tetra Discovery Partners Online and Social Media Presence

Tetra Discovery Partners Company Life and Culture

You may also be interested in